[Announcement] HGPI Endorsed “Urgent Joint Statement on the Treatment of Comprehensive Genomic Profiling Test in the Revision of Medical Service Fee in FY2024” (June 19, 2024)
date : 6/19/2024
Tags: NCDs, Precision Cancer Medicine
On June 19, 2024, Health and Global Policy Institute (HGPI) endorsed the “Urgent Joint Statement on the Treatment of Comprehensive Genomic Profiling Tests in the Revision of Medical Service Fee in FY2024.”
In addition to our Organization, this Joint Statement is endorsed by the Japan Federation of Cancer Patient Groups, the European Federation of Pharmaceutical Industries and Associations (EFPIA Japan), the Japanese Society of Medical Oncology, and the Japanese Society of Clinical Oncology.
In “Joint Statement on the Implementation of Comprehensive Genomic Profiling test” of December 15, 2023, we requested that “Expand insurance coverage for cancer gene panel testing so that it can be done at the appropriate time from the time of initial treatment.” However, since this request was not approved in the 2024 revision of medical service fees, the organizations concerned have decided to once again jointly prepare this statement in order to provide appropriate medical care to patients. This joint statement will be submitted to the Minister of Health, Labour and Welfare, Mr. Keizo Takemi, and other relevant officials.
Currently, the cancer gene panel tests (cancer comprehensive genomic profiling tests) approved for use under the Japanese health insurance system is only for “solid tumors for which no standard treatment is available, or with local progression or metastasis for which standard treatment has been terminated (including those for whom termination is expected)”.
Under these circumstances, we are concerned that patients will miss the opportunity to select the optimal therapeutic agent. We are also concerned that even if a comprehensive genomic profiling test is performed after the completion of standard treatment and a gene mutation that can be treated with drug therapy is found, the patient will continue to miss the opportunity for treatment due to the deterioration of his/her general condition, resulting in an unfortunate situation where it is too late.
Please note that the joint statement documents are only available in Japanese.
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)